NASDAQ

Cadrenal Therapeutics, Inc. (CVKD)

♥ 692 Thanks from members

Live price chart, market sentiment, and community perspectives for Cadrenal Therapeutics, Inc. (NASDAQ: CVKD).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Cardrenal Therapeutics TeamLeadership: Todd Girolamo (CEO)Leadership: Rey Del Valle (CFO)Holder: Fidelity ManagementHolder: Institutional InsidersHolder: Retail InvestorsCardioplegia SolutionsTefibazumabCardiovascular Therapeutics#CVKD#Cadrenal Therapeutics#Biotech#Cardiovascular#NASDAQ CVKD